Skip to main content
. 2017 Jun 27;28(10):2588–2594. doi: 10.1093/annonc/mdx332

Figure 2.

Figure 2.

Overall survival among non-small-cell lung cancer (NSCLC) patients according to receipt of whole brain radiotherapy stratified by diagnosis-specific Graded Prognostic Assessment (GPA) score (per-protocol). NSCLC patients (n =175) were stratified according to GPA scores of <2.5 (unfavorable) and ≥2.5 (favorable).